Navigation Links
Later Use of Clot-Buster After Stroke Possible: Study
Date:9/14/2008

tPA can be safely given beyond the current 3-hour limit, international researchers find

SUNDAY, Sept. 14 (HealthDay News) -- European researchers who showed that the clot-dissolving drug tPA could safely be used within three hours after a stroke now say the limit can be extended to four-and-a-half hours.

"We now have a three-hour limit mandated by authorities," said Dr. Nils Wahlgren, a neurology professor at the Karolinska Institute in Sweden and leader of an international group reporting Sunday in the online version of The Lancet. "Our data indicate that it is safe to extend that from three hours to four-and-a-half hours. The risk of hemorrhagic complications is not significantly different from the earlier time limit."

Tissue plasminogen activator (tPA), also known as the drug alteplase, is the approved treatment for the most common kind of stroke, in which a blood clot blocks a brain artery. The three-hour post-stroke time limit has been set because of fears that use of the clot-dissolving drug beyond that period might cause dangerous bleeding or other complications.

The new report is the latest from a study requested by European authorities after doubts arose about the safety of tPA in stroke treatment, which was approved in 1996 by the U.S. Food and Drug Administration. It was approved in 2002 in Europe.

The study compared the outcomes of 664 people who were given tPA between three and four-and-a-half hours after a stroke against almost 12,000 who received the drug within three hours of an attack.

The study found a death rate of 12.7 percent in the following three months for the three-hour group and 12.2 percent for those getting tPA later. In the early group, 58 percent achieved the ability of independent action, compared to 56.3 percent in the later-administration group.

"We recorded no significant differences between the 3- to 4.5-hour cohort and the within 3-hour coho
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. 6 Years Later, 9/11 Health Questions Linger
2. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
3. SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System
4. Early treatment of children with bilateral amblyopia essential, according to multisite study
5. AAAAI: Early Day Care Attendance May Protect Infants From Later Developing Asthma, From the Journal of Allergy and Clinical Immunology
6. Dementia in More Educated Hits Later But Harder
7. Contamination from depleted uranium found in urine 20 years later
8. Early Weight Gain Can Mean Heart Trouble Later in Life
9. Fetal heart rate yields clues to childrens later development
10. Fetal Heart Rate Points to Later Child Development
11. Trauma earlier in life may affect response to stress years later
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Later Use of Clot-Buster After Stroke Possible: Study
(Date:6/18/2013)... Exposed Skin Care has finally been released after much anticipation ... finally achieve the clear, beautiful skin they have always dreamed ... system combines the power of science and nature to both ... , After a quick review of Exposed Skin ... most effective available on the market to cure acne both ...
(Date:6/18/2013)... Recent studies linking bullying and depression, coupled with ... people, led the Centers for Disease Control and ... focus on these issues. This panel synthesized the ... involvement in bullying and suicide-related behaviors. Three themes ... public health problem, with widespread and often harmful ...
(Date:6/18/2013)... An apple a day might really keep ... with breast cancer, she chose a different method for ... Myself Cancer, I Can Take It Away!: Alternatives Brought ... explains how changing her physical, mental and emotional diet ... made to feel fearful when diagnosed with a disease ...
(Date:6/18/2013)... Cheap Concert Tickets has released additional inventories ... gets underway in July. Soccer fans can add code ... , The popularity and hype of soccer has ... the hype of the game triggered the sports-minded citizens of ... the veins of fans from the Caribbean. The adrenalin ...
(Date:6/18/2013)... As obesity rates sky rocket in the United ... during childbirth comes as no shock. Forceps are surgical equipment ... she is unable to do so herself and although they ... rates of complication for both the mother and the baby. ... and child, forceps births add to the pressure of healthcare ...
Breaking Medicine News(10 mins):Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:Bullying and suicide among youth is a public health problem 2Health News:Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2
... Mayo Clinic researchers have discovered that a chemical known ... for the effectiveness of tamoxifen in treating breast cancer, ... unexpected way. , Their study, being presented at the ... (CTRC-AACR) 31st annual San Antonio Breast Cancer Symposium, finds ...
... their lower back pain are better off than those who ... a University of Alberta study. , The study, done in ... cent improvement in pain and function levels for people with ... of resistance training using dumbbells, barbells and other load-bearing exercise ...
... Liverpool Associates in Tropical Health (LATH), a consulting arm ... a 10 million contract to manage a programme of ... initiative in Malawi. , Led by the National ... 5 year programme supported by the Wellcome Trust, the ...
... large proteomics study on the brains of newborn mice ... obstetric or pediatric medicine can have profound and long-term ... study, appearing in the December issue of Molecular ... the developing nervous system and reinforces the use of ...
... TCM Inc. of West Chester, PA ... named PCM Solutions, LLC, with Nalco Company ... the process industries, such as chemical and petrochemical manufacturing, ... paper manufacturing, food and beverage production, and various other ...
... Enhances First Global Medical Donations Map , ... The Partnership for Quality Medical Donations (PQMD) Mapping Tool, ... to information about the medical product donations being made ... to the world,s most vulnerable populations. Both the ...
Cached Medicine News:Health News:Mayo Clinic researchers find tamoxifen's power comes from endoxifen 2Health News:Mayo Clinic researchers find tamoxifen's power comes from endoxifen 3Health News:LATH wins contract to boost health research capacity in Malawi 2Health News:The profound effects of numbing agents 2Health News:Haas TCM Inc. Forms PCM Solutions, LLC, a Joint Venture With Nalco Company, to Provide Chemical Management Services (CMS) to the Process Industries 2Health News:Global Mapping Tool Demonstrates Medical Donation Impact 2Health News:Global Mapping Tool Demonstrates Medical Donation Impact 3
(Date:6/18/2013)... June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... on the development and commercialization of novel bile acid ... pricing of an underwritten public offering of 1,730,000 shares ... of $33.01 per share.  In addition, Intercept has granted ... an additional 259,500 shares of common stock. ...
(Date:6/18/2013)... 18, 2013  Actavis, Inc. (NYSE: ACT ) ... the U.S. Securities and Exchange Commission (SEC) a registration statement ... Warner Chilcott plc (NASDAQ: WCRX ), ... Warner Chilcott (the "Form S-4"). As previously ... have entered into a definitive agreement pursuant to which ...
(Date:6/18/2013)...  Recent regulatory and budget challenges have made it ... large pharmaceutical companies to effectively educate doctors and other ... their new products. With the pressure to reduce budgets ... these "Med Ed" groups find practical, economical ... the changes that are transforming the Medical Education area ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2
... May 5, 2011 Novartis Pharmaceuticals Corporation ("Novartis") announced ... approved Afinitor® (everolimus) tablets for the treatment of progressive ... unresectable, locally advanced or metastatic disease(4). This marks the ... in the US in nearly 30 years(5). ...
... FRANCISCO, May 5, 2011 Cardiac Network, Inc. (Other OTC: ... a 1-for-750 reverse stock split (the "Reverse Stock Split"). The ... business and trading on May 6, 2011 (the "Effective Date"). ... changed from "CNWI" to "CNWID" for approximately 20 business days, ...
Cached Medicine Technology:Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 2Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 3Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 4Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 5Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 6Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 7Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 8Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 9Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET 10Cardiac Network Announces Reverse Stock Split 2
Hollow Copper Tube with Suction Port 16.5....
Aluminum Stylette 16 with Adjustable Stop....
Ultra-Slip™ endotracheal tube guide for single-patient use only., ,Caution: Not MRI Compatible....
Aluminum Stylette 16....
Medicine Products: